164 related articles for article (PubMed ID: 1617494)
1. Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Lioté F; Bardin C; Liou A; Brouard A; Terrier JL; Kuntz D
Calcif Tissue Int; 1992 Mar; 50(3):209-13. PubMed ID: 1617494
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.
Erlacher L; Teufelsbauer H; Bernecker P; Pietschmann P; Weissel M
Clin Investig; 1994 Dec; 72(12):1082-5. PubMed ID: 7711420
[TBL] [Abstract][Full Text] [Related]
3. Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets.
van Asten P; Duursma SA; Glerum JH; Ververs FF; van Rijn HJ; van Dijk A
Eur J Clin Pharmacol; 1996; 50(4):321-6. PubMed ID: 8803527
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.
Setnikar I; Maurer H
Arzneimittelforschung; 1990 Sep; 40(9):994-9. PubMed ID: 2080951
[TBL] [Abstract][Full Text] [Related]
5. Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.
Sakhaee K; Pak CY
Bone Miner; 1991 Aug; 14(2):131-6. PubMed ID: 1912761
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
Setnikar I; Maurer H
Arzneimittelforschung; 1990 Mar; 40(3):323-8. PubMed ID: 2346544
[TBL] [Abstract][Full Text] [Related]
8. In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
Rigalli A; Pera L; Morosano M; Masoni A; Bocanera R; Tozzini R; Puche RC
Medicina (B Aires); 1999; 59(2):157-61. PubMed ID: 10413893
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.
Setnikar I; Rovati LC; Schmid K; Vens-Cappell B; Barkworth MF
Arzneimittelforschung; 1998 Dec; 48(12):1172-8. PubMed ID: 9893933
[TBL] [Abstract][Full Text] [Related]
10. Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets.
Arnold P; Wermeille M; Chapuy MC; Biollaz J; Grandjean EM; Schelling JL; Meunier PJ
Bone; 1989; 10(6):401-7. PubMed ID: 2624820
[TBL] [Abstract][Full Text] [Related]
11. Fluoride bioavailability from disodium monofluorophosphate fluoridated milk in children and rats.
Villa A; Guerrero S; Cisternas P; Monckeberg F
Caries Res; 1989; 23(3):179-83. PubMed ID: 2736581
[TBL] [Abstract][Full Text] [Related]
12. A comparison of fluoride bioavailability from a sustained-release NaF preparation (Neosten) and other fluoride preparations.
Gitomer WL; Sakhaee K; Pak CY
J Clin Pharmacol; 2000 Feb; 40(2):138-41. PubMed ID: 10664919
[TBL] [Abstract][Full Text] [Related]
13. Influence of milk and food on fluoride bioavailability from NaF and Na2FPO3 in man.
Trautner K; Einwag J
J Dent Res; 1989 Jan; 68(1):72-7. PubMed ID: 2910959
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of fluoride administered as sodium fluoride or sodium monofluorophosphate to human volunteers.
Rigalli A; Morosano M; Puche RC
Arzneimittelforschung; 1996 May; 46(5):531-3. PubMed ID: 8737641
[TBL] [Abstract][Full Text] [Related]
15. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C
Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994
[TBL] [Abstract][Full Text] [Related]
16. Fluoride therapy of type I osteoporosis.
Devogelaer JP; Nagant de Deuxchaisnes C
Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658
[TBL] [Abstract][Full Text] [Related]
17. Influence of food on relative bioavailability of fluoride in man from Na2FPO3-containing tablets for the treatment of osteoporosis.
Trautner K
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):242-9. PubMed ID: 2737790
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.
Warneke G; Setnikar I
Arzneimittelforschung; 1993 May; 43(5):584-90. PubMed ID: 8329004
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic differences between sodium fluoride and sodium monofluorophosphate and comparative bone mass increasing activity of both compounds in the rat.
Rigalli A; Ballina JC; Beinlich AD; Alloatti R; Puche RC
Arzneimittelforschung; 1994 Jun; 44(6):762-6. PubMed ID: 8053977
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the fluoride bioavailability from two oral preparations of monofluorophosphate disodium in combination with various calcium salts].
Brazier M; Fardelonne P; Bellony R; Sebert JL; Desmet G; Hary L; Richard MO
Therapie; 1990; 45(3):235-41. PubMed ID: 2363111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
